在一个资源有限的中东国家,诊断的挑战和经典基尿的结果
Nadine Yazbeck1, Rudy N Zalzal2, Fadi El Oueichek2
1Division of Gastroenterology and Nutrition, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
International journal of pediatrics
|September 8, 2025
概括
限制氨的饮食似乎可以支持患有古典氨尿症 (PKU) 的儿童的生长. 然而,黎巴嫩的晚期诊断和有限的新生儿查阻碍了PKU患者的神经类型的发展.
科学领域:
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 关于在低收入中东国家诊断和结果的PKU诊断数据有限.
- 普基饮食对生长的影响仍然是争论的主题.
- 这项研究调查了黎巴嫩的PKU诊断,结果和增长.
研究的目的:
- 检查经典PKU患者的诊断,结果和成长.
- 评估限制氨酸的地中海饮食对生长参数的影响.
- 分析在资源有限的环境中实现神经典型结果的挑战.
主要方法:
- 在黎巴嫩医疗中心对PKU患者 (2008-2023) 的15年回顾性图表审查.
- 分析诊断时的年龄,分子概况,神经状态,人体测量,饮食和代谢控制.
- 包括标准适用于82份审查的患者病历中的35份.
主要成果:
- 大多数患者 (35/82) 的诊断迟到 (平均年龄:4岁),导致神经学结果不佳.
- 在63%的患者中,常见的地中海PKU变体IVS10-11G>A在63%的患者中被发现具有同胞性.
- 在饮食患者的研究期间,没有观察到BMI或身高对年龄z-score的显著差异.
结论:
- 限制氨酸的地中海饮食可以在经典的PKU中保持生长参数.
- 由于黎巴嫩缺乏系统的新生儿查,实现神经类型的结果具有挑战性.
- 高血缘关系率和资源限制进一步使黎巴嫩的PKU管理复杂化.
相关概念视频
Inborn Errors of Metabolism
699
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
699
Overview of Protein Metabolism
3.7K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Chronic Kidney Disease III: Interprofessional Care
346
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
346
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214


